litlas
ログインアカウント作成

G. Caleb Alexander

1998–2026 年に発表

別表記
G Caleb Alexander · G Caleb-Alexander
162
論文数
20,277
被引用数
78
h 指数
152
i10 指数

被引用数

G. Caleb Alexander の年別被引用数1968 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 8 件2001 年: 被引用 3 件2002 年: 被引用 5 件2003 年: 被引用 13 件2004 年: 被引用 11 件2005 年: 被引用 20 件2006 年: 被引用 17 件2007 年: 被引用 23 件2008 年: 被引用 27 件2009 年: 被引用 37 件2010 年: 被引用 50 件2011 年: 被引用 49 件2012 年: 被引用 86 件2013 年: 被引用 75 件2014 年: 被引用 77 件2015 年: 被引用 91 件2016 年: 被引用 127 件2017 年: 被引用 180 件2018 年: 被引用 175 件2019 年: 被引用 733 件2020 年: 被引用 755 件2021 年: 被引用 822 件2022 年: 被引用 746 件2023 年: 被引用 431 件2024 年: 被引用 748 件2025 年: 被引用 272 件2026 年: 被引用 13 件1969〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,270 件、この内訳の 41.8%イギリス: 引用元論文 521 件、この内訳の 6.7%カナダ: 引用元論文 493 件、この内訳の 6.3%中国: 引用元論文 308 件、この内訳の 3.9%オーストラリア: 引用元論文 281 件、この内訳の 3.6%イタリア: 引用元論文 231 件、この内訳の 3%ドイツ: 引用元論文 208 件、この内訳の 2.7%オランダ: 引用元論文 187 件、この内訳の 2.4%スペイン: 引用元論文 136 件、この内訳の 1.7%スウェーデン: 引用元論文 131 件、この内訳の 1.7%フランス: 引用元論文 128 件、この内訳の 1.6%日本: 引用元論文 118 件、この内訳の 1.5%
0%41.8%その他 23.1%

機関

分野

  • Medicine78.2%
  • Health Professions3.3%
  • Economics, Econometrics and Finance2.9%
  • Pharmacology, Toxicology and Pharmaceutics2.6%
  • Biochemistry, Genetics and Molecular Biology2.6%
  • Psychology2.4%
  • その他8%

トピック

  • Opioid Use Disorder Treatment7.5%
  • Substance Abuse Treatment and Outcomes3%
  • Pharmaceutical Practices and Patient Outcomes2.8%
  • Pain Management and Opioid Use2.7%
  • HIV, Drug Use, Sexual Risk2.5%
  • Atrial Fibrillation Management and Outcomes2.3%
  • その他79.2%

共著者

全論文

検索で開く
  1. National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020

    著者: Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha - Journal of the American Heart Association 2022 被引用: 158

  2. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes

    著者: Justin Reese, Hannah Blau, Elena Casiraghi, Timothy Bergquist, Johanna Loomba, Tiffany J. Callahan, Bryan Laraway, Corneliu Antonescu, Ben Coleman, Michael Gargano, Kenneth J. Wilkins, Luca Cappelletti, Tommaso Fontana, Nariman Ammar, Blessy Antony, T. M. Murali, J. Harry Caufield, Guy Karlebach, Julie A. McMurry, Andrew E. Williams, Richard A. Moffitt, Jineta Banerjee, Anthony Solomonides, Hannah Davis, Kristin Kostka, Giorgio Valentini, David Sahner, Christopher G. Chute, Charisse Madlock‐Brown, Melissa Haendel, Peter N. Robinson, Heidi Spratt, Shyam Visweswaran, Joseph E Flack, Yun Jae Yoo, Davera Gabriel, G. Caleb Alexander, Hemalkumar B. Mehta, Feifan Liu, Robert Miller, Rachel Wong, Elaine Hill, Lorna E. Thorpe, Jasmin Divers - EBioMedicine 2022 被引用: 177

  3. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011

    著者: Dima M. Qato, Jocelyn Wilder, L. Philip Schumm, Victoria Gillet, G. Caleb Alexander - JAMA Internal Medicine 2016 被引用: 656

  4. Evaluation of Aducanumab for Alzheimer Disease

    著者: G. Caleb Alexander, Scott S. Emerson, Aaron S. Kesselheim - JAMA 2021 被引用: 234

  5. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016

    著者: Thomas J. Moore, Hanzhe Zhang, Gerard F. Anderson, G. Caleb Alexander - JAMA Internal Medicine 2018 被引用: 355

  6. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

    著者: Andrew Kolodny, David T. Courtwright, Catherine S. Hwang, Peter Kreiner, John L. Eadie, Thomas W. Clark, G. Caleb Alexander - Annual Review of Public Health 2015 被引用: 1,401

  7. Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US

    著者: G. Caleb Alexander, Matthew Tajanlangit, James Heyward, Omar Mansour, Dima M. Qato, Randall S. Stafford - JAMA Network Open 2020 被引用: 490

  8. The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms

    著者: Christopher M. Jones, Faraah Bekheet, Ju Nyeong Park, G. Caleb Alexander - Epidemiologic Reviews 2020 被引用: 190

  9. Prescription Opioid Analgesics Commonly Unused After Surgery

    著者: Mark C. Bicket, Jane J. Long, Peter J. Pronovost, G. Caleb Alexander, Christopher L. Wu - JAMA Surgery 2017 被引用: 870

  10. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate

    著者: Yao Qiao, Jung‐Im Shin, Teresa K. Chen, Lesley A. Inker, Josef Coresh, G. Caleb Alexander, John W. Jackson, Alex R. Chang, Morgan E. Grams - JAMA Internal Medicine 2020 被引用: 204

  11. Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

    著者: Thomas J. Moore, James Heyward, Gerard F. Anderson, G. Caleb Alexander - BMJ Open 2020 被引用: 112

  12. Revisiting FDA Approval of Aducanumab

    著者: G. Caleb Alexander, David S. Knopman, Scott S. Emerson, Bruce Ovbiagele, Richard J. Kryscio, Joel S. Perlmutter, Aaron S. Kesselheim - New England Journal of Medicine 2021 被引用: 164

  13. Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease

    著者: Hai V. Nguyen, Shweta Mital, David S. Knopman, G. Caleb Alexander - Neurology 2024 被引用: 73

  14. Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis

    著者: Ayobami Akenroye, Grace Lassiter, John W. Jackson, Corinne Keet, Jodi B Segal, G. Caleb Alexander, Hwanhee Hong - Journal of Allergy and Clinical Immunology 2022 被引用: 70

  15. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation

    著者: Ayobami Akenroye, Jodi B Segal, Guohai Zhou, Dinah Foer, Lily Li, G. Caleb Alexander, Corinne Keet, John W. Jackson - Journal of Allergy and Clinical Immunology 2023 被引用: 56

  16. Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States

    著者: Dima M. Qato, G. Caleb Alexander, Rena M. Conti, Michael Johnson, L. Philip Schumm, Stacy Tessler Lindau - JAMA 2008 被引用: 1,005

  17. Fewer Pharmacies In Black And Hispanic/Latino Neighborhoods Compared With White Or Diverse Neighborhoods, 2007–15

    著者: Jenny S. Guadamuz, Jocelyn Wilder, Morgane C. Mouslim, Shannon N. Zenk, G. Caleb Alexander, Dima M. Qato - Health Affairs 2021 被引用: 123

  18. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis

    著者: Irene B. Murimi, Dora H. Lin, Henk Nab, Hong Kan, Oluwadamilola Onasanya, Jonothan C. Tierce, Xia Wang, Barnabas Desta, G. Caleb Alexander, Edward R. Hammond - BMJ Open 2020 被引用: 104

  19. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis

    著者: Tanawin Nopsopon, Grace Lassiter, Ming‐Li Chen, G. Caleb Alexander, Corinne Keet, Hwanhee Hong, Ayobami Akenroye - Journal of Allergy and Clinical Immunology 2022 被引用: 70

  20. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

    著者: Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William H. Crown, Víctor M. Montori, Lindsey R. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A. Noseworthy - Journal of the American Heart Association 2016 被引用: 451

  21. Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals

    著者: Ayobami Akenroye, James Heyward, Corinne Keet, G. Caleb Alexander - The Journal of Allergy and Clinical Immunology In Practice 2021 被引用: 66

  22. The availability of pharmacies in the United States: 2007–2015

    著者: Dima M. Qato, Shannon N. Zenk, Jocelyn Wilder, Rachel Harrington, Darrell J. Gaskin, G. Caleb Alexander - PLoS ONE 2017 被引用: 186

  23. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

    著者: Xueying Yang, Jing Sun, Rena C. Patel, Jiajia Zhang, Siyuan Guo, Qulu Zheng, Amy L. Olex, Bankole Olatosi, Sharon Weissman, Jessica Y. Islam, Christopher G. Chute, Melissa Haendel, Gregory D. Kirk, Xiaoming Li, Richard A. Moffitt, Hana Akelsrod, Keith A. Crandall, Nora Francheschini, Evan French, Teresa Po‐Yu Chiang, G Caleb-Alexander, Kathleen M. Andersen, Amanda J. Vinson, Todd T. Brown, Roslyn B. Mannon - The Lancet HIV 2021 被引用: 165

  24. Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis

    著者: James Heyward, Omar Mansour, Lily Olson, Sonal Singh, G. Caleb Alexander - PLoS ONE 2020 被引用: 107